RxDoctor Payments Data

Abdalla Abdalla Ali

Pediatrics · Lansing, MINPI 1134101074

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $265 and has fallen 74.7% since, to $67 in 2025.

$969in general payments, 2019–2025

Across 55 payments — averaging $17.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$133
  • Otsuka America Pharmaceutical, Inc.$115
  • Merck$74
  • Gilead$67
  • Biohaven Pharmaceutical Holding Company Ltd.$66
  • Takeda Pharmaceuticals U.S.A., Inc.$59
  • plus $455 from 17 others

What the payments were for

  • Food & beverage$969100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$969 in reported general payments places this provider in the 80th percentile of 1,473 pediatrics providers in Michigan.

See all pediatrics providers in Michigan →

Other pediatrics in Lansing

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →